131 related articles for article (PubMed ID: 2575424)
1. Brief intermittent neuroleptic prophylaxis for selected schizophrenic out-patients.
McClelland HA; Harrison G; Soni SD
Br J Psychiatry; 1989 Nov; 155():702-6. PubMed ID: 2575424
[No Abstract] [Full Text] [Related]
2. Psychotic recurrence after antipsychotic discontinuation.
Zipursky RB
Am J Psychiatry; 2002 Aug; 159(8):1441-2; author reply 1442. PubMed ID: 12153856
[No Abstract] [Full Text] [Related]
3. Intermittent vs maintenance medication in schizophrenia. Two-year results.
Herz MI; Glazer WM; Mostert MA; Sheard MA; Szymanski HV; Hafez H; Mirza M; Vana J
Arch Gen Psychiatry; 1991 Apr; 48(4):333-9. PubMed ID: 1672588
[TBL] [Abstract][Full Text] [Related]
4. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
5. Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year.
Jolley AG; Hirsch SR; McRink A; Manchanda R
BMJ; 1989 Apr; 298(6679):985-90. PubMed ID: 2567190
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic withdrawal in schizophrenic patients. A review of the literature.
Gilbert PL; Harris MJ; McAdams LA; Jeste DV
Arch Gen Psychiatry; 1995 Mar; 52(3):173-88. PubMed ID: 7872841
[No Abstract] [Full Text] [Related]
7. Maintenance therapy and the natural course of schizophrenia.
Davis JM
J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):18-21. PubMed ID: 2865252
[TBL] [Abstract][Full Text] [Related]
8. Discontinuation of neuroleptic medication in older, outpatient schizophrenics. A placebo-controlled, double-blind trial.
Ruskin PE; Nyman G
J Nerv Ment Dis; 1991 Apr; 179(4):212-4. PubMed ID: 1672547
[TBL] [Abstract][Full Text] [Related]
9. Treating prodromal episodes to prevent relapse in schizophrenia.
Herz MI; Glazer W; Mirza M; Mostert M; Hafez H
Br J Psychiatry Suppl; 1989 Jul; (5):123-7. PubMed ID: 2574984
[No Abstract] [Full Text] [Related]
10. [What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
Müller P
Nervenarzt; 1983 Sep; 54(9):477-85. PubMed ID: 6138720
[No Abstract] [Full Text] [Related]
11. Carbamazepine maintenance treatment in outpatient schizophrenics.
Carpenter WT; Kurz R; Kirkpatrick B; Hanlon TE; Summerfelt AT; Buchanan RW; Waltrip RW; Breier A
Arch Gen Psychiatry; 1991 Jan; 48(1):69-72. PubMed ID: 1670617
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine as an adjunct to conventional antipsychotic treatment of schizophrenia patients with residual symptoms.
Arango C; Kirkpatrick B; Buchanan RW
J Nerv Ment Dis; 2000 Jan; 188(1):50-3. PubMed ID: 10665462
[No Abstract] [Full Text] [Related]
13. Antipsychotic medication: clinical guidelines for maintenance therapy.
Johnson DA
J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
[TBL] [Abstract][Full Text] [Related]
14. The costs of drugs for schizophrenia.
Freedman R; Carpenter WT; Davis JM; Goldman HH; Tamminga CA; Thomas M
Am J Psychiatry; 2006 Dec; 163(12):2029-31. PubMed ID: 17151146
[No Abstract] [Full Text] [Related]
15. Placebo-controlled trial of glycine added to clozapine in schizophrenia.
Evins AE; Fitzgerald SM; Wine L; Rosselli R; Goff DC
Am J Psychiatry; 2000 May; 157(5):826-8. PubMed ID: 10784481
[TBL] [Abstract][Full Text] [Related]
16. Continuous versus targeted medication in schizophrenic outpatients: outcome results.
Carpenter WT; Hanlon TE; Heinrichs DW; Summerfelt AT; Kirkpatrick B; Levine J; Buchanan RW
Am J Psychiatry; 1990 Sep; 147(9):1138-48. PubMed ID: 1974743
[TBL] [Abstract][Full Text] [Related]
17. Maintenance therapy and schizophrenia.
Leff JP
Br J Psychiatry; 1975; Spec No 9():55-8. PubMed ID: 241453
[No Abstract] [Full Text] [Related]
18. Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophrenia.
Dellva MA; Tran P; Tollefson GD; Wentley AL; Beasley CM
Psychiatr Serv; 1997 Dec; 48(12):1571-7. PubMed ID: 9406266
[TBL] [Abstract][Full Text] [Related]
19. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.
Inderbitzin LB; Lewine RR; Scheller-Gilkey G; Swofford CD; Egan GJ; Gloersen BA; Vidanagama BP; Waternaux C
Am J Psychiatry; 1994 Dec; 151(12):1753-9. PubMed ID: 7977881
[TBL] [Abstract][Full Text] [Related]
20. New antipsychotic medications: strategies for evaluation and selected findings.
Schooler NR
Schizophr Res; 1997 Oct; 27(2-3):249-59. PubMed ID: 9416654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]